Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hollis Eden Pharmaceuticals Inc. (HEPH) -- Ignore unavailable to you. Want to Upgrade?

To: incomep who wrote (49)	3/27/1998 10:00:00 PM
From: BDR	Read Replies (1) \| Respond to of 138

<I will be able to use my recent regulatory experience gained at Gilead Sciences, while working on its nucleotide analog for the treatment of HIV infection, to assist in the development of the lead product candidates at Hollis-Eden.> I interpret this sentence to mean that she will use the regulatory experience she gained while working on the nucleotide analog of Gilead Sciences to assist in the development of other products at HEPH. She isn't saying that HEPH's product is a nucleotide analog.